Will is an Associate Director in our private equity team, and advises financial sponsors, management teams and portfolio companies on a range of transactions, including management buy-outs, exits, executing buy and build strategies, management equity incentive arrangements,  group and debt restructures, and other general corporate matters.  

Will leads the Osborne Clarke Portfolio Group, a cross-discipline group of expert lawyers experienced in supporting investors and management teams realise the potential of their investments on exit, through a combination of strategic value add projects, minimising legal and regulatory risk, and business as usual matters.

Will is a core member of the Mobility and Infrastructure and Urban Mobility.

Helping you succeed in tomorrow's world

I am a passionate advocate for the use of legal technology in my work, and work closely with Osborne Clarke's in-house legal technology team, OC Solutions, to deliver greater efficiencies and value to deal and in-house legal teams.

Kester Capital

Kester Capital and the management team on the sale of Vixio Regulatory Intellgence to European private equity investor, Perwyn.

Read more
Medivet

Medivet, a CVC portfolio company and one of the most acquisitive companies in the UK, on its acquisition and integration documentation and processes.

Vimian Group AB

Vimian Group AB, a Swedish animal health conglomerate backed by Fidelio Capital, on its expansion in the UK market through multiple bolt-on acquisitions.

Osborne Clarke advises Vimian Group on its acquisition of Freelance Surgical - Osborne Clarke | Osborne Clarke

Tenzing Private Equity

Tenzing Private Equity and the management team on the sale of Citnow to Livingbridge.

Osborne Clarke has advised Tenzing and management shareholders on the sale of CitNOW to Livingbridge and Tenzing's reinvestment - Osborne Clarke | Osborne Clarke

Contact William
  • +44 207 105 7930
  • English
    • Follow